Filing Details
- Accession Number:
- 0001144204-14-049045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-12 21:00:34
- Reporting Period:
- 2014-08-09
- Filing Date:
- 2014-08-12
- Accepted Time:
- 2014-08-12 21:00:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283972 | Dr R Klaus Veitinger | C/O Intercept Pharmaceuticals, Inc. 450 W. 15Th Street, Suite 505 New York NY 10011 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-09 | 324 | $0.00 | 2,330 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-11 | 64 | $234.71 | 2,266 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-08-11 | 6 | $238.25 | 2,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-08-11 | 93 | $238.26 | 2,167 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-08-11 | 1 | $238.28 | 2,166 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-11 | 391 | $21.50 | 2,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-11 | 391 | $239.49 | 2,166 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2014-08-09 | 324 | $0.00 | 324 | $0.00 |
| Common Stock | Options to Purchase Common Stock | Disposition | 2014-08-11 | 391 | $0.00 | 391 | $21.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 12,198 | 2022-11-16 | No | 4 | M | Direct |
Footnotes
- The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person either on June 26, 2013 or May 13, 2014.
- Conversion of restricted stock units ("RSU") to shares of common stock on a one-for one-basis.
- On November 16, 2012, the reporting person was granted 2,596 RSUs. The RSUs reported as having been disposed and the corresponding shares reported as having been acquired, representing 12.5% of the shares underlying the RSUs, became vested on August 9, 2014, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan.
- All shares underlying this option have vested.
Billionaire Hedge Funds
